MarketPeel
Insider Trading Intelligence
Pricing
…
PF

Peter C. Farrell

EOLS
DIRECTOR · EVOLUS, INC. · CIK 0001186102
FILING MIX · LIFETIME45%/55%
BUYS
26
SELLS
32
TOTAL VALUE
$19.18M
COMPANIES
3
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
118,947
AVG SELL PX
$229.96
TRADE KIND
SHOWING 58 / 58
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
21 backtested trades · 8 horizons · 27 pending
Forward-return performance of every backtestable P/S trade by Peter C. Farrell, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d21+61.90%-0.35%+0.17%-0.52%-0.51%—
14d21+66.67%-0.93%+0.14%-1.07%-1.57%—
30d21+52.38%-0.68%+0.74%-1.43%-1.85%—
60d21+47.62%-1.82%+1.12%-2.65%-0.61%—
90d21+52.38%-1.21%+3.89%-3.84%-0.74%—
180d21(4 pending)+58.82%+0.10%+7.47%-5.86%-1.43%—
1y21(6 pending)+40.00%-0.52%+17.84%-16.71%-10.55%—
2y21(17 pending)+25.00%+29.54%+45.07%-15.53%-18.93%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
EOLS · 43,174 shares · as of Jan 27, 2023
010,79421,58732,38143,174202120222023SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 26 buys / 32 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
PURCHASEGRANT
Stock grant
15,000——15,000Jun 5, 2026Jun 15, 2026 ↗View →
RMD
RESMED INC
SALE10b5-1
10b5-1 plan
2,000$225.00$450.0K60,773Apr 1, 2026Apr 2, 2026 ↗View →
RMD
RESMED INC
SALE10b5-1
10b5-1 plan
2,000$260.22$520.4K62,773Mar 4, 2026Mar 5, 2026 ↗View →
RMD
RESMED INC
SALE10b5-1
10b5-1 plan
2,000$251.31$502.6K64,773Feb 4, 2026Feb 5, 2026 ↗View →
RMD
RESMED INC
SALE10b5-1
10b5-1 plan
2,000$248.83$497.7K66,773Jan 7, 2026Jan 8, 2026 ↗View →
RMD
RESMED INC
SALE10b5-1
10b5-1 plan
2,000$251.47$502.9K68,773Dec 3, 2025Dec 4, 2025 ↗View →
RMD
RESMED INC
PURCHASEGRANT
Stock grant
1,331$250.52$333.4K1,331Nov 24, 2025Nov 26, 2025 ↗View →
RMD
RESMED INC
PURCHASEGRANT
Stock grant
536——70,773Nov 20, 2025Nov 21, 2025 ↗View →
RMD
RESMED INC
SALE
7,314$244.46$1.79M70,238Nov 14, 2025Nov 18, 2025 ↗View →
RMD
RESMED INC
PURCHASE
11,442$101.64$1.16M77,552Nov 14, 2025Nov 18, 2025 ↗View →
RMD
RESMED INC
SALE
11,442——0Nov 14, 2025Nov 18, 2025 ↗View →
RMD
RESMED INC
SALE10b5-1
10b5-1 plan
2,000$252.05$504.1K66,110Nov 12, 2025Nov 13, 2025 ↗View →
RMD
RESMED INC
SALE
162.953$250.10$40.8K68,110Nov 11, 2025Nov 13, 2025 ↗View →
RMD
RESMED INC
SALE10b5-1
10b5-1 plan
945$255.49$241.4K68,273Jul 2, 2025Jul 2, 2025 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
PURCHASEGRANT
Stock grant
15,000——15,000Jun 9, 2025Jun 11, 2025 ↗View →
RMD
RESMED INC
SALE10b5-1
10b5-1 plan
2,000$247.32$494.6K69,218Jun 4, 2025Jun 5, 2025 ↗View →
RMD
RESMED INC
SALE10b5-1
10b5-1 plan
2,000$242.25$484.5K71,218May 7, 2025May 8, 2025 ↗View →
RMD
RESMED INC
SALE10b5-1
10b5-1 plan
2,000$219.74$439.5K73,218Apr 2, 2025Apr 3, 2025 ↗View →
RMD
RESMED INC
SALE10b5-1
10b5-1 plan
2,000$227.71$455.4K75,218Mar 5, 2025Mar 6, 2025 ↗View →
RMD
RESMED INC
SALE10b5-1
10b5-1 plan
2,000$242.11$484.2K77,218Feb 5, 2025Feb 5, 2025 ↗View →
RMD
RESMED INC
SALE10b5-1
10b5-1 plan
2,000$230.99$462.0K79,218Jan 2, 2025Jan 3, 2025 ↗View →
RMD
RESMED INC
SALE10b5-1
10b5-1 plan
2,000$245.65$491.3K81,218Dec 4, 2024Dec 5, 2024 ↗View →
RMD
RESMED INC
PURCHASEGRANT
Stock grant
1,468$249.56$366.4K1,468Nov 25, 2024Nov 26, 2024 ↗View →
RMD
RESMED INC
PURCHASEGRANT
Stock grant
542——83,218Nov 20, 2024Nov 21, 2024 ↗View →
RMD
RESMED INC
SALE
527.905$252.38$133.2K82,676Nov 11, 2024Nov 12, 2024 ↗View →
RMD
RESMED INC
SALE10b5-1
10b5-1 plan
2,000$248.74$497.5K83,204Nov 6, 2024Nov 7, 2024 ↗View →
RMD
RESMED INC
SALE10b5-1
10b5-1 plan
2,000$237.20$474.4K85,204Oct 2, 2024Oct 2, 2024 ↗View →
RMD
RESMED INC
SALE10b5-1
10b5-1 plan
2,000$239.90$479.8K87,204Sep 4, 2024Sep 6, 2024 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
PURCHASE
3,131——55,741Jun 14, 2024Jun 18, 2024 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE
3,131——0Jun 14, 2024Jun 18, 2024 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
PURCHASEGRANT
Stock grant
15,000——15,000Jun 14, 2024Jun 18, 2024 ↗View →
RMD
RESMED INC
SALEGRANT
Gift
68,200——89,204May 15, 2024May 16, 2024 ↗View →
RMD
RESMED INC
SALE
10,935$182.66$2.00M157,404Feb 22, 2024Feb 23, 2024 ↗View →
RMD
RESMED INC
PURCHASEGRANT
Stock grant
1,768——180,939Nov 16, 2023Nov 20, 2023 ↗View →
RMD
RESMED INC
SALE
325.375$143.60$46.7K179,171Nov 13, 2023Nov 15, 2023 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
PURCHASEGRANT
Stock grant
11,869——11,869Aug 1, 2023Aug 3, 2023 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
PURCHASEGRANT
Stock grant
3,131——3,131Aug 1, 2023Aug 3, 2023 ↗View →
RMD
RESMED INC
SALE
12,600$237.17$2.99M166,896May 3, 2023Feb 23, 2024 ↗View →
EOLS
EVOLUS, INC.
PURCHASEGRANT
Stock grant
11,789——11,789Jan 27, 2023Jan 31, 2023 ↗View →
EOLS
EVOLUS, INC.
PURCHASEGRANT
Stock grant
8,293——43,174Jan 27, 2023Jan 31, 2023 ↗View →
RMD
RESMED INC
PURCHASEGRANT
Stock grant
1,122——179,496Nov 16, 2022Nov 18, 2022 ↗View →
RMD
RESMED INC
SALE
128$225.18$28.8K178,374Nov 11, 2022Nov 15, 2022 ↗View →
RMD
RESMED INC
SALE
9,050$221.98$2.01M183,052Oct 31, 2022Nov 2, 2022 ↗View →
RMD
RESMED INC
SALEGRANT
Gift
4,550——178,502Oct 31, 2022Nov 2, 2022 ↗View →
EOLS
EVOLUS, INC.
PURCHASE
10,000$9.10$91.0K10,000Sep 6, 2022Sep 6, 2022 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
PURCHASEGRANT
Stock grant
15,000——15,000Jun 23, 2022Jun 27, 2022 ↗View →
EOLS
EVOLUS, INC.
PURCHASEGRANT
Stock grant
15,568——34,881Jan 24, 2022Jan 26, 2022 ↗View →
EOLS
EVOLUS, INC.
PURCHASEGRANT
Stock grant
22,727——22,727Jan 24, 2022Jan 26, 2022 ↗View →
RMD
RESMED INC
PURCHASEGRANT
Stock grant
1,695——1,695Nov 18, 2021Nov 22, 2021 ↗View →
RMD
RESMED INC
PURCHASEGRANT
Stock grant
478——192,102Nov 18, 2021Nov 22, 2021 ↗View →
RMD
RESMED INC
SALE
342$259.47$88.7K191,624Nov 11, 2021Nov 12, 2021 ↗View →
RMD
RESMED INC
SALEGRANT
Gift
36,670——191,966Aug 13, 2021Aug 17, 2021 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
PURCHASEGRANT
Stock grant
15,000——15,000Jun 18, 2021Jun 22, 2021 ↗View →
EOLS
EVOLUS, INC.
PURCHASEGRANT
Stock grant
19,313——19,313Feb 5, 2021Feb 9, 2021 ↗View →
RMD
RESMED INC
PURCHASEGRANT
Stock grant
1,187——228,636Nov 19, 2020Nov 20, 2020 ↗View →
RMD
RESMED INC
SALE
579$212.11$122.8K227,449Nov 11, 2020Nov 13, 2020 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
PURCHASEGRANT
Stock grant
15,000——15,000Jun 22, 2020Jun 24, 2020 ↗View →
EOLS
EVOLUS, INC.
PURCHASEGRANT
Stock grant
23,458——23,458Jan 23, 2020Jan 24, 2020 ↗View →
Other insiders · EOLS
Loading peer insiders…
About this filer
CIK 0001186102
ROLE
Director
PRIMARY
EOLS
COMPANIES
3
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001186102DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback